Literature DB >> 22171276

Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus.

Daniel Olal1, Ana I Kuehne, Shridhar Bale, Peter Halfmann, Takao Hashiguchi, Marnie L Fusco, Jeffrey E Lee, Liam B King, Yoshihiro Kawaoka, John M Dye, Erica Ollmann Saphire.   

Abstract

Antibody 14G7 is protective against lethal Ebola virus challenge and recognizes a distinct linear epitope in the prominent mucin-like domain of the Ebola virus glycoprotein GP. The structure of 14G7 in complex with its linear peptide epitope has now been determined to 2.8 Å. The structure shows that this GP sequence forms a tandem β-hairpin structure that binds deeply into a cleft in the antibody-combining site. A key threonine at the apex of one turn is critical for antibody interaction and is conserved among all Ebola viruses. This work provides further insight into the mechanism of protection by antibodies that target the protruding, highly accessible mucin-like domain of Ebola virus and the structural framework for understanding and characterizing candidate immunotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171276      PMCID: PMC3302272          DOI: 10.1128/JVI.05549-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Recent developments in the PHENIX software for automated crystallographic structure determination.

Authors:  Paul D Adams; Kreshna Gopal; Ralf W Grosse-Kunstleve; Li-Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Reetal K Pai; Randy J Read; Tod D Romo; James C Sacchettini; Nicholas K Sauter; Laurent C Storoni; Thomas C Terwilliger
Journal:  J Synchrotron Radiat       Date:  2003-11-28       Impact factor: 2.616

2.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

3.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

Authors:  J M Rini; U Schulze-Gahmen; I A Wilson
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

4.  Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.

Authors:  R L Stanfield; T M Fieser; R A Lerner; I A Wilson
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

5.  Standard conformations for the canonical structures of immunoglobulins.

Authors:  B Al-Lazikani; A M Lesk; C Chothia
Journal:  J Mol Biol       Date:  1997-11-07       Impact factor: 5.469

6.  Epitopes involved in antibody-mediated protection from Ebola virus.

Authors:  J A Wilson; M Hevey; R Bakken; S Guest; M Bray; A L Schmaljohn; M K Hart
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

7.  Recombinant human monoclonal antibodies to Ebola virus.

Authors:  T Maruyama; P W Parren; A Sanchez; I Rensink; L L Rodriguez; A S Khan; C J Peters; D R Burton
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

Authors:  A Sanchez; S G Trappier; B W Mahy; C J Peters; S T Nichol
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.

Authors:  Ayato Takada; Heinz Feldmann; Ute Stroeher; Mike Bray; Shinji Watanabe; Hiroshi Ito; Martha McGregor; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  A shared structural solution for neutralizing ebolaviruses.

Authors:  João M Dias; Ana I Kuehne; Dafna M Abelson; Shridhar Bale; Anthony C Wong; Peter Halfmann; Majidat A Muhammad; Marnie L Fusco; Samantha E Zak; Eugene Kang; Yoshihiro Kawaoka; Kartik Chandran; John M Dye; Erica Ollmann Saphire
Journal:  Nat Struct Mol Biol       Date:  2011-11-20       Impact factor: 15.369

View more
  35 in total

1.  IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

Authors:  Johan Nilvebrant; D Cameron Dunlop; Aroop Sircar; Thierry Wurch; Emilia Falkowska; Janice M Reichert; Gustavo Helguera; Emily C Piccione; Simon Brack; Sven Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody.

Authors:  Ki Joon Cho; Bert Schepens; Kristof Moonens; Lei Deng; Walter Fiers; Han Remaut; Xavier Saelens
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

3.  Structural and molecular basis for Ebola virus neutralization by protective human antibodies.

Authors:  John Misasi; Morgan S A Gilman; Masaru Kanekiyo; Miao Gui; Alberto Cagigi; Sabue Mulangu; Davide Corti; Julie E Ledgerwood; Antonio Lanzavecchia; James Cunningham; Jean Jacques Muyembe-Tamfun; Ulrich Baxa; Barney S Graham; Ye Xiang; Nancy J Sullivan; Jason S McLellan
Journal:  Science       Date:  2016-02-25       Impact factor: 47.728

4.  Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography.

Authors:  Erin E H Tran; James A Simmons; Alberto Bartesaghi; Charles J Shoemaker; Elizabeth Nelson; Judith M White; Sriram Subramaniam
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

5.  New monoclonal antibodies to the Ebola virus glycoprotein: Identification and analysis of the amino acid sequence of the variable domains.

Authors:  A A Panina; T K Aliev; O B Shemchukova; I G Dement'yeva; N E Varlamov; L P Pozdnyakova; M N Bokov; D A Dolgikh; P G Sveshnikov; M P Kirpichnikov
Journal:  Dokl Biochem Biophys       Date:  2016-05-20       Impact factor: 0.788

6.  Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.

Authors:  Adrián Lázaro-Frías; Sergio Gómez-Medina; Lucas Sánchez-Sampedro; Karl Ljungberg; Mart Ustav; Peter Liljeström; César Muñoz-Fontela; Mariano Esteban; Juan García-Arriaza
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Structures of protective antibodies reveal sites of vulnerability on Ebola virus.

Authors:  Charles D Murin; Marnie L Fusco; Zachary A Bornholdt; Xiangguo Qiu; Gene G Olinger; Larry Zeitlin; Gary P Kobinger; Andrew B Ward; Erica Ollmann Saphire
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

8.  Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.

Authors:  Anne-Laure Favier; Evelyne Gout; Olivier Reynard; Olivier Ferraris; Jean-Philippe Kleman; Viktor Volchkov; Christophe Peyrefitte; Nicole M Thielens
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

9.  A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.

Authors:  Robert H Bortz; Anthony C Wong; Michael G Grodus; Hannah S Recht; Marc C Pulanco; Gorka Lasso; Simon J Anthony; Eva Mittler; Rohit K Jangra; Kartik Chandran
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

Review 10.  Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.

Authors:  Everardo González-González; Mario Moisés Alvarez; Alan Roberto Márquez-Ipiña; Grissel Trujillo-de Santiago; Luis Mario Rodríguez-Martínez; Nasim Annabi; Ali Khademhosseini
Journal:  Crit Rev Biotechnol       Date:  2015-11-26       Impact factor: 8.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.